PropThink: ENDP's Deep Discount Won't Last; Upside Scenarios Are Icing on

PropThink: ENDP's Deep Discount Won't Last; Upside Scenarios Are Icing On

Filed under: drug treatment news stories

The drug is expected to achieve peak sales of approximately $ 950 million this year, but will begin to decline next year on the entry of generic competition. The ENDP story is far from the first time that investors have dealt with drug companies losing …
Read more on Reuters

 

Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate

Filed under: drug treatment news stories

The goal of the Phase 2 study will be to evaluate the safety, tolerability and viral cure rates of a 12-week regimen of simeprevir and VX-135, administered with and without ribavirin, in treatment-naive patients who have chronic non-cirrhotic genotype …
Read more on Sacramento Bee

 

Voice of recovery being heard

Filed under: drug treatment news stories

Nori St. Paul is a nationally published writer based in Naples, writing on community and national interest stories and inspirational profiles. Her work includes exploring the resources of healing from mental illness and addiction. More than 300 …
Read more on The News-Press